• Study Cancellations Undercut Site Viability, Stakeholders Say

    Aug 28 | Clinical Research News | In an environment where clinical trial budgets are scrutinized and timelines compressed, the human and operational toll of cancelled studies poses a serious threat. It undercuts site stability, strains patient engagement, and jeopardizes future collaboration. A recent SCOPE 365 ClinEco Connect session convened industry veterans across sites, sponsors, and CROs to seek a solution. More

  • Follow the Money: Supplying Global Clinical Trials, Novel Next-Gen Biosensor, More

    Aug 27 | Clinical Research News | ARTBIO plans to rapidly advance its manufacturing network infrastructure to supply global clinical trials and commercialization, as well as their pipeline of alpha radioligand therapies; Sava Technologies will accelerate regulatory approval and commercialization of its next-generation wearable; and more. More

  • International Progressive MS Alliance Launches Data Platform, N-Power Launches Novel Platform, More

    Aug 26 | Clinical Research News | The International Progressive MS Alliance launched its MS Clinical and Imaging Data Resource (CIDR); N-Power Medicine announced the launch of the industry’s first Prospective External Control Arm (ProECA) platform; and more. More

  • Navigating the Complexities of Radiopharmaceutical Therapy Trials

    Aug 21 | Clinical Research News | Radiopharmaceutical therapy (RPT) has been around for a long time now, but advances in technology and understanding of the actionable molecular pathways that drive cancer have fueled a resurgence in interest and investment in the therapeutic modality. he popularity of RPTs is driven largely by theranostics combining diagnostic imaging and targeted therapy into a single, integrated system to more precisely deliver radiation to tumor cells and thereby minimize damage to healthy tissue. More

  • Non-Invasive Medical Devices Show Clinical Promise Across Multiple Indications

    Aug 19 | Clinical Research News | Clinical trials and preclinical studies are demonstrating the therapeutic potential of Openwater's infrared light and low-intensity focused ultrasound technologies across a diverse range of medical conditions, from cancer treatment to stroke diagnosis. More

  • Latin America the ‘Hidden Gem’ for First-in-Human Medical Device Trials

    Aug 14 | Clinical Research News | The big holdup in the development of advanced medical devices seems inevitably to happen at the point where first-in-human clinical trials are to begin, at least if the studies are to be conducted in the U.S. where it can be difficult to find clinical leaders, recruit patients, and bear the overall financial burden of their execution. More

  • Regulatory Proposals Good Match to Priorities of New FDA

    Aug 13 | Clinical Research News | Regardless of how one views the priorities of the Food and Drug Administration (FDA) under the new administration, it’s an opportunity for badly needed change to “shake things up,” according to Doug Bain, founder and consulting partner of UK-based ClinFlo, a newly launched consulting and service company focused on the application of technology to improve clinical research. More

  • How Non-Profits Are Contributing to the Clinical Research Landscape

    Aug 12 | Clinical Research News | The clinical research landscape is undergoing a significant transformation, with nonprofit organizations emerging as pivotal players in accelerating drug development for rare diseases. In the most recent episode of the Scope of Things podcast, Annette Bakker, CEO of the Children's Tumor Foundation (CTF), shared insights into how nonprofits are revolutionizing the clinical research ecosystem. More

  • Five Clinical Trends Shaping the Future of TMF Strategy

    Aug 08 | Clinical Research News | The trial master file (TMF) is the backbone of clinical trials, ensuring completeness of documentation and compliance for studies. Yet, TMF is still perceived as a file repository. Biopharma and CRO leaders are advancing their approach to make TMF a more strategic tool for study management and oversight. More

  • Fluorescence-Guided Surgery Shows Promise in Clinical Trials for Cancer Detection

    Aug 05 | Clinical Research News | Researchers are making significant strides in fluorescence-guided surgery, with dozens of glowing molecular probes currently under investigation in clinical trials to help surgeons better visualize tumor margins during operations. The technology could revolutionize surgical precision and eventually enable autonomous robotic surgery. More
View more articles
 
DXX-Industry-spotlight
SOT

The Scope of Things podcast explores clinical research and its possibilities, promise, and pitfalls. Clinical Research News Senior writer Deborah Borfitz welcomes guests who are visionaries closest to the topics, but who can still see past their piece of the puzzle. Focusing on game-changing trends and out-of-the-box operational approaches in the clinical research field, the Scope of Things podcast is your no-nonsense, insider’s look at clinical research today.

Read More